TLR7 and systemic lupus erythematosus: Increase in Tlr7 gene dosage in non-autoimmune mice promotes the development of a lupus-like disease, whereas, the deletion of the Tlr7 allele in lupus-prone mice eliminates anti-RNA auto-Abs and reduces disease pathology (4, 5, 7, 8).